Inhibition of Angiogenesis by HC·HA, a Complex of Hyaluronan and the Heavy Chain of Inter-α-inhibitor, Purified from Human Amniotic Membrane

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2011 Jan 14

PMID 21228375

Citations 30

Authors

Elizabeth Shay

Hua He

Shunsuke Sakurai

Scheffer C G Tseng

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine whether antiangiogenic action of the amniotic membrane (AM) can be mediated by HC·HA, a covalent complex of hyaluronan (HA) and the heavy chain (HC) of inter-α-inhibitor, purified from AM soluble extract.

Methods: HC·HA action on viability, proliferation, attachment, death, migration, and differentiation of human umbilical vein endothelial cells (HUVECs) and neovascularization in chicken chorioallantoic membrane (CAM) was examined by MTT assay, BrdU labeling, cell proliferation assay, cell death detection ELISA, transwell assay, tube formation assay, and CAM assay.

Results: HC·HA suppressed HUVEC viability more significantly than HA and AM stromal extract, and such suppression was not mediated by CD44. HC·HA also caused HUVECs to become small and rounded, with a decrease in spreading and filamentous actin. Without promoting cell detachment or death, HC·HA dose dependently inhibited proliferation (IC(50), 2.3 μg/mL) and was 100-fold more potent than HA. Migration triggered by VEGF and tube formation was also significantly inhibited by HC·HA. Purified HC·HA did not contain PEDF and TSP-1 but did contain IGFBP-1 and platelet factor 4 while significantly suppressing neovascularization in CAM.

Conclusions: The antiangiogenic activity of HC·HA might explain why AM is developmentally avascular and how AM might exert an antiangiogenic action when transplanted to the ocular surface, and it might indicate a potential therapeutic effect of HC·HA in diseases manifesting pathogenic angiogenesis. Roles of IGFBP-1 and platelet factor 4 in HC·HA antiangiogenic action warrant further investigation.

Citing Articles

A novel therapeutic approach for endometriosis using adipose-derived stem cell-derived conditioned medium- A new hope for endometriotic patients in improving fertility.

Huang S, Huang C, Huang Y, Cheng J, Yu Y, Lai J Front Endocrinol (Lausanne). 2023; 14:1158527.

PMID: 37293500 PMC: 10244723. DOI: 10.3389/fendo.2023.1158527.

Inter-Alpha Inhibitor Proteins Modify the Microvasculature after Exposure to Hypoxia-Ischemia and Hypoxia in Neonatal Rats.

Girolamo F, Lim Y, Virgintino D, Stonestreet B, Chen X Int J Mol Sci. 2023; 24(7).

PMID: 37047713 PMC: 10094872. DOI: 10.3390/ijms24076743.

The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures.

Sharma R, Nappi V, Empeslidis T Int Ophthalmol. 2023; 43(5):1771-1783.

PMID: 36715957 PMC: 10149474. DOI: 10.1007/s10792-022-02570-5.

Amniotic membrane transplantation in a patient with impending perforated corneal ulcer caused by : A case report and review of literature.

Hsiao F, James Meir Y, Yeh L, Tan H, Hsiao C, Ma D World J Clin Cases. 2022; 10(12):3923-3929.

PMID: 35647159 PMC: 9100738. DOI: 10.12998/wjcc.v10.i12.3923.

Periosteum and development of the tissue-engineered periosteum for guided bone regeneration.

Zhang W, Wang N, Yang M, Sun T, Zhang J, Zhao Y J Orthop Translat. 2022; 33:41-54.

PMID: 35228996 PMC: 8858911. DOI: 10.1016/j.jot.2022.01.002.

References

Li W, He H, Kawakita T, Espana E, Tseng S . Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro. Exp Eye Res. 2005; 82(2):282-92. PMC: 3193177. DOI: 10.1016/j.exer.2005.06.022. View

Jessen T, Odum L . Role of tumour necrosis factor stimulated gene 6 (TSG-6) in the coupling of inter-alpha-trypsin inhibitor to hyaluronan in human follicular fluid. Reproduction. 2003; 125(1):27-31. DOI: 10.1530/rep.0.1250027. View

Kawakita T, Espana E, He H, Hornia A, Yeh L, OuYang J . Keratocan expression of murine keratocytes is maintained on amniotic membrane by down-regulating transforming growth factor-beta signaling. J Biol Chem. 2005; 280(29):27085-92. PMC: 1282515. DOI: 10.1074/jbc.M409567200. View

Ben Lagha N, Seurin D, Le Bouc Y, Binoux M, Berdal A, Menuelle P . Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice. Endocrinology. 2006; 147(10):4730-7. DOI: 10.1210/en.2006-0171. View

Watson C, Bialek P, Anzo M, Khosravi J, Yee S, Han V . Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology. 2005; 147(3):1175-86. DOI: 10.1210/en.2005-0606. View

Rugg M, Willis A, Mukhopadhyay D, Hascall V, Fries E, Fulop C . Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan. J Biol Chem. 2005; 280(27):25674-86. DOI: 10.1074/jbc.M501332200. View

Rooney P, Kumar S, Ponting J, Wang M . The role of hyaluronan in tumour neovascularization (review). Int J Cancer. 1995; 60(5):632-6. DOI: 10.1002/ijc.2910600511. View

Kruse F, Joussen A, Rohrschneider K, You L, Sinn B, Baumann J . Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol. 2000; 238(1):68-75. DOI: 10.1007/s004170050012. View

Han Y, Lee J, Jung J, Lee J . Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2008; 247(4):541-8. DOI: 10.1007/s00417-008-0976-3. View

10.

Wijelath E, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z . Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res. 2006; 99(8):853-60. PMC: 3175430. DOI: 10.1161/01.RES.0000246849.17887.66. View

11.

Fulop C, Szanto S, Mukhopadhyay D, Bardos T, Kamath R, Rugg M . Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development. 2003; 130(10):2253-61. DOI: 10.1242/dev.00422. View

12.

Tseng S, Espana E, Kawakita T, Di Pascuale M, Li W, He H . How does amniotic membrane work?. Ocul Surf. 2007; 2(3):177-87. DOI: 10.1016/s1542-0124(12)70059-9. View

13.

Jiang A, Li C, Gao Y, Zhang M, Hu J, Kuang W . In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization. Cornea. 2006; 25(10 Suppl 1):S36-40. DOI: 10.1097/01.ico.0000247211.78391.af. View

14.

Tseng S, Prabhasawat P, Barton K, Gray T, Meller D . Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998; 116(4):431-41. DOI: 10.1001/archopht.116.4.431. View

15.

West D, Kumar S . The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res. 1989; 183(1):179-96. DOI: 10.1016/0014-4827(89)90428-x. View

16.

Jouan V, Canron X, Alemany M, Caen J, Quentin G, Plouet J . Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood. 1999; 94(3):984-93. View

17.

Kim J, Tseng S . The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J Ophthalmol. 1995; 9(1):32-46. DOI: 10.3341/kjo.1995.9.1.32. View

18.

Ma D, Yao J, Yeh L, Liang S, See L, Chen H . In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane. Invest Ophthalmol Vis Sci. 2004; 45(8):2586-95. DOI: 10.1167/iovs.03-1338. View

19.

McKEE C, Penno M, Cowman M, Burdick M, Strieter R, Bao C . Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996; 98(10):2403-13. PMC: 507693. DOI: 10.1172/JCI119054. View

20.

He H, Li W, Tseng D, Zhang S, Chen S, Day A . Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane. J Biol Chem. 2009; 284(30):20136-46. PMC: 2740440. DOI: 10.1074/jbc.M109.021881. View